A significant breakthrough in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential cancer suppressor protein is frequently disabled in many forms of cancer, causing https://bookmarkingace.com/story21975532/nanobodies-reactivate-p53-new-new-pathway-for-cancer-therapy